ES8600273A1 - Un procedimiento para producir 2,6-dimetil-4-(3nitrofenil)-1,4-dihidropiridin 3,5-dicarboxilato de 1, bencil-3-piperidilo y metilo y su hidrocloruro. - Google Patents

Un procedimiento para producir 2,6-dimetil-4-(3nitrofenil)-1,4-dihidropiridin 3,5-dicarboxilato de 1, bencil-3-piperidilo y metilo y su hidrocloruro.

Info

Publication number
ES8600273A1
ES8600273A1 ES526441A ES526441A ES8600273A1 ES 8600273 A1 ES8600273 A1 ES 8600273A1 ES 526441 A ES526441 A ES 526441A ES 526441 A ES526441 A ES 526441A ES 8600273 A1 ES8600273 A1 ES 8600273A1
Authority
ES
Spain
Prior art keywords
dihydropyridine
ester
piperidyl
nitrophenyl
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526441A
Other languages
English (en)
Other versions
ES526441A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57180616A external-priority patent/JPS5970667A/ja
Priority claimed from JP58011719A external-priority patent/JPS59137461A/ja
Priority claimed from JP58098899A external-priority patent/JPS59225162A/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of ES526441A0 publication Critical patent/ES526441A0/es
Publication of ES8600273A1 publication Critical patent/ES8600273A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR 2,6-DIMETIL-4-(3-NITROFENIL)-1,4-DIHIDROPIRIDIN-3,5-DICARBOXILATO DE 1-BENCIL-3-PIPERIDILO Y METILO Y SU HIDROCLORURO.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) O UN DERIVADO REACTIVO DEL MISMO CON UN ALCOHOL DE FORMULA (III) EN UNA PROPORCION MOLAR DE 1/0,8 A 1/2 RESPECTIVAMENTE, A UNA TEMPERATURA DE C70JC A 100JC, EN PRESENCIA DE UN DISOLVENTE INERTE POLAR ATROPICO COMO ACETONITRILO Y UN AGENTE CONDENSANTE PARA OBTENER UN COMPUESTO DE FORMULA (I), SU HIDROCLORURO Y SUS DIFERENTES ISOMEROS OPTICOS O SU MEZCLA RACIMICA, CUYO HIDROCLORURO TIENE UN PUNTO DE FUSION DE 196 A 202JC. EL RACEMATO Y LOS ISOMEROS OPTICOS SE PUEDEN SEPARAR DE LAS SALES DERIVADAS POR CROMATOGRAFIA O CRISTALIZACION.SE UTILIZAN EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES.
ES526441A 1982-10-15 1983-10-13 Un procedimiento para producir 2,6-dimetil-4-(3nitrofenil)-1,4-dihidropiridin 3,5-dicarboxilato de 1, bencil-3-piperidilo y metilo y su hidrocloruro. Expired ES8600273A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP57180616A JPS5970667A (ja) 1982-10-15 1982-10-15 １，４−ジヒドロピリジン誘導体
JP58011719A JPS59137461A (ja) 1983-01-27 1983-01-27 １，４−ジヒドロピリジン誘導体
JP58098899A JPS59225162A (ja) 1983-06-03 1983-06-03 １，４−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
ES526441A0 ES526441A0 (es) 1985-10-01
ES8600273A1 true ES8600273A1 (es) 1985-10-01

Family

ID=27279541

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526441A Expired ES8600273A1 (es) 1982-10-15 1983-10-13 Un procedimiento para producir 2,6-dimetil-4-(3nitrofenil)-1,4-dihidropiridin 3,5-dicarboxilato de 1, bencil-3-piperidilo y metilo y su hidrocloruro.

Country Status (7)

Country Link
EP (1) EP0106275B1 (es)
KR (1) KR860001946B1 (es)
AU (1) AU557175B2 (es)
CA (1) CA1246078A (es)
DE (1) DE3382204D1 (es)
ES (1) ES8600273A1 (es)
MX (1) MX156034A (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204336B (it) * 1986-05-05 1989-03-01 Luso Farmaco Inst Processo per la preparazione di 2-(n-benzil-n-metilammino)-etil-metil1,4-diidro-2,6-dimetil-4-(3-nitrofenil)-3,5-piridin-dicarbossilato cloridrato
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
BR0313593A (pt) 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
ATE551059T1 (de) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN102746215A (zh) 2011-04-18 2012-10-24 张兆勇 一种制备高纯度盐酸贝尼地平的方法
CN102351784B (zh) * 2011-10-20 2013-10-30 华夏药业集团有限公司 一种盐酸贝尼地平晶型及其应用
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
CN103641774B (zh) * 2013-11-26 2015-07-08 湖南方盛制药股份有限公司 盐酸贝尼地平的制备方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104529872B (zh) * 2014-12-10 2018-07-10 天津长源医药科技有限公司 一种盐酸贝尼地平中间体的合成方法
WO2019053491A1 (en) 2017-09-15 2019-03-21 Deva Holding Anonim Sirketi CRYSTALLINE BENIDIPINE HCL SOLID FORMS AND PROCESSES FOR PREPARING THE SAME
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof
CN112679416A (zh) * 2020-12-31 2021-04-20 济南朗科医药技术有限公司 一种盐酸贝尼地平的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2659665A1 (de) * 1976-12-30 1978-07-13 Nattermann A & Cie Neue 1,4-dihydropyridin-derivate
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
EP0106275A2 (en) 1984-04-25
AU1989883A (en) 1984-04-19
EP0106275A3 (en) 1984-05-23
ES526441A0 (es) 1985-10-01
DE3382204D1 (de) 1991-04-18
AU557175B2 (en) 1986-12-11
MX156034A (es) 1988-06-16
KR860001946B1 (ko) 1986-11-01
KR840006644A (ko) 1984-12-01
EP0106275B1 (en) 1991-03-13
CA1246078A (en) 1988-12-06

Similar Documents

Publication Publication Date Title
ES8600273A1 (es) Un procedimiento para producir 2,6-dimetil-4-(3nitrofenil)-1,4-dihidropiridin 3,5-dicarboxilato de 1, bencil-3-piperidilo y metilo y su hidrocloruro.
JPS55301A (en) 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DK163120C (da) Analogifremgangsmaade til fremstilling af substituerede acylderivater af 1,2,3,4-tetrahydroisoquinolin-3-carboxylsyre (s,s,s) eller et farmaceutisk acceptabelt salt deraf
NL930054I2 (nl) Nieuwe 2,6-dimethyl-4-(2,3-dichlorofenyl)-1,4-dihydropyridine-3,5-dicarbonzuur-3-methylester-5-ethylester met hypotensieve eigenschappen alsmede werkwijze voor de bereiding ervan en farmaceutische preparaten, die deze bevatten.
JPS57171968A (en) 1,4-dihydropyridine derivative
DK333683A (da) Fremgangsmaade til fremstilling af 2-heteroaryl-alkoxymethyl-4-(aryl eller heteroaryl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf
GB1455502A (en) 1,4-dihydropyridine derivatives
FI882001A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-(2-aminoetoksimetyyli)-4-(2-kloorifenyyli)-3-etoksikarbonyyli-5-metoksikarbonyyli-6-metyyli-1,4-dihydropyridiinien valmistamiseksi
DK355784A (da) 2-(heterocyclylalkoxymethyl)-4-(aryl eller heteroaryl)-6-methyl-1,4-dihydropyridin-3,5- dicarboxylsyreestere og deres anvendelse til behandling af cardiovasculaere lidelser samt farmaceutiske praeparater indeholdende disse forbindelser
AU590690B2 (en) Asymmetrical ester derivatives of 1,4-dihydropyridine-3, 5-dicarboxylic acid
BE1003199A5 (fr) Procede de preparation des derives de 1,4-dihydropyridine et a de nouveaux intermediaires utiles pour cette preparation.
DK0531845T3 (da) Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester
AU569618B2 (en) Dihydropyridine -3,5 -dicarboxylic acid ester derivatives
NO166643C (no) Fremg.maate for fremst. av den hoeyredreiende, optiske isomer av diastereomer a av ym-09730, med kjem. navn (+)-2,6-dimethyl-4-(n-nitrofenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester.
EP0260605A3 (en) Dihydropyridine-5-phosphonic acid cyclic ester
JPS5287174A (en) Preparation of novel 2-amino 1,4-dihydropyridine derivatives
FI853574L (fi) Dihydropyridin -3,5-dikarboxylsyraesterderivat.
DK32789A (da) Derivat af antibiotikum a 42867
ATE126190T1 (de) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-
KR900007831A (ko) 1,4-디히드로피리딘 유도체
TH591A (th) กรรมวิธีในการผลิตอนุพันธ์ของ 1-ซัลโฟ-2-แอเซทิดิโนน
TH591EX (th) กรรมวิธีในการผลิตอนุพันธ์ของ 1-ซัลโฟ-2-แอเซทิดิโนน

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050613